May 12 (Reuters) - Emergent BioSolutions Inc :
* EMERGENT BIOSOLUTIONS - ISSUED A STATEMENT ON STATUS OF RESPONSE TO FDA'S OBSERVATIONS RELATED TO COMPANY'S BALTIMORE BAYVIEW FACILITY
* EMERGENT BIOSOLUTIONS - CONTINUE TO HAVE ON-GOING DIALOGUE WITH FDA & JOHNSON & JOHNSON AS WE WORK TO RELEASE DRUG SUBSTANCE, RESUME PRODUCTION
* EMERGENT BIOSOLUTIONS - HAVE ALREADY STARTED MAKING IMPROVEMENTS, CO FULLY COMMITTED TO MAKING NECESSARY ENHANCEMENTS TO MEET/EXCEED FDA'S STANDARDS
Source: [ Further company coverage:
((reuters.briefs@thomsonreuters.com;))